24 June 2021

GH Research PLC Announces Pricing of Initial Public Offering

Read press release here

12 April 2021

GH Research Announces Closing of $125 Million Oversubscribed Series B Financing

Read press release here

19 November 2020

GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress

Read press release here


GH Research is funded by multiple top-tier biopharmaceutical investment firms.